Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence
Abstract
While melatonin was once thought of simply as a sleep-inducing hormone, recent research has resulted in development of a deeper understanding of the complex physiological activity of melatonin in the human body. Along with this understanding has come widespread, increasing use of melatonin supplementation, extending beyond its traditional use as a sleep aid into novel fields of application. This increased use often involves off-label and self-prescription, escalating the importance of safety data. In order to examine the current knowledge relating to safety of the exogenous neurohormone, we conducted a comprehensive, critical systematic review of clinical evidence. We examined controlled studies of oral melatonin supplementation in humans when they presented any statistical analysis of adverse events. Of the fifty articles identified, twenty-six found no statistically significant adverse events, while twenty-four articles reported on at least one statistically significant adverse event. Adverse events were generally minor, short-lived and easily managed, with the most commonly reported adverse events relating to fatigue, mood, or psychomotor and neurocognitive performance. A few studies noted adverse events relating to endocrine (e.g. reproductive parameters, glucose metabolism) and cardiovascular (e.g. blood pressure, heart rate) function, which appear to be influenced by dosage, dose timing and potential interactions with antihypertensive drugs. Oral melatonin supplementation in humans has a generally favourable safety profile with some exceptions. Most adverse effects can likely be easily avoided or managed by dosing in accordance with natural circadian rhythms. Further research is required to explore the potential for melatonin to interact with endogenous hormones and pharmaceuticals.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Oral melatonin is mostly perceived as safe based on published reports, even in higher doses.
“Oral melatonin is mostly perceived as safe based on published reports, even in higher doses [300]; however, there can be specific instances that may necessitate further diligence and clinical oversight.”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [300]
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · see citing works
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371 · see citing works
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593 · see citing works
Riemersma-van der Lek, R. F. (2008) · JAMA · doi:10.1001/jama.299.22.2642 · Cited by 803 · see citing works
The Safety of Melatonin in Humans
Andersen, L. P. H., Gögenür, I., Rosenberg, J., & Reiter, R. J. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0368-5 · Cited by 474 · see citing works
Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension
Scheer, F. A. J. L., Van Montfrans, G. A., van Someren, E. J. W., Mairuhu, G., & Buijs, R. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000113293.15186.3b · Cited by 451 · see citing works
A Multicenter, Placebo-controlled Trial of Melatonin for Sleep Disturbance in Alzheimer's Disease
Singer, C., Tractenberg, R. E., Kaye, J., Schafer, K., Gamst, A., Grundman, M., Thomas, R., & Thal, L. J. (2003) · Sleep · doi:10.1093/sleep/26.7.893 · Cited by 407 · see citing works
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders
Auld, F., Maschauer, E. L., Morrison, I., Skene, D. J., & Riha, R. L. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.06.005 · Cited by 402 · see citing works
Wolden‐Hanson, T., Mitton, D. R., McCants, R. L., Yellon, S. M., Wilkinson, C. W., Matsumoto, A. M., & Rasmussen, D. D. (2000) · Endocrinology · doi:10.1210/endo.141.2.7311 · Cited by 390 · see citing works
Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia
VAN der HEIJDEN, K. B., SMITS, M. G., VAN SOMEREN, E. J. W., RIDDERINKHOF, K. R., & GUNNING, W. B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246055.76167.0d · Cited by 378 · see citing works
Lewy, A. J., Bauer, V. K., Ahmed, S., Thomas, K. H., Cutler, N. L., Singer, C. M., Moffit, M. T., & Sack, R. L. (1998) · Chronobiology International · doi:10.3109/07420529808998671 · Cited by 360 · see citing works
Koziróg, M., Poliwczak, A. R., Duchnowicz, P., Koter-Michalak, M., Sikora, J., & Broncel, M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00835.x · Cited by 299 · see citing works
Seabra, M. D. L. V., Bignotto, M., Pinto, L. R., & Tufik, S. B. (2000) · Journal of Pineal Research · doi:10.1034/j.1600-0633.2002.290401.x · Cited by 280 · see citing works
Evidence for a circadian rhythm of insulin secretion
Boden, G., Ruiz, J., Urbain, J. L., & Chen, X. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.2.e246 · Cited by 261 · see citing works
Black, L. I., Clarke, T. C., Barnes, P. M., Stussman, B. J., & Nahin, R. L. (2015) · PubMed · Cited by 246 · see citing works
Voordouw, B. C., Euser, R., Verdonk, R. E., Alberda, B. T., de Jong, F. H., Drogendijk, A. C., Fauser, B. C. J. M., & Cohen, M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.1.1727807 · Cited by 239 · see citing works
Effects of melatonin on human mood and performance
Lieberman, H. R., Waldhauser, F., Garfield, G. S., Lynch, H. J., & Wurtman, R. J. (1984) · Brain Research · doi:10.1016/0006-8993(84)90290-7 · Cited by 217 · see citing works
Wright, B., Sims, D., Smart, S., Alwazeer, A., Alderson‐Day, B., Allgar, V. L., Whitton, C., Tomlinson, H., Bennett, S. D., Jardine, J., et al. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1036-5 · Cited by 196 · see citing works
Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening
Rubio-Sastre, P., Scheer, F. A. J. L., Gómez-Abellán, P., Madrid, J. A., & Garaulet, M. (2014) · SLEEP · doi:10.5665/sleep.4088 · Cited by 180 · see citing works
Melatonin as Adjuvant Cancer Care With and Without Chemotherapy
Seely, D., Wu, P., Fritz, H., Kennedy, D. A., Tsui, T. C. O., SEELY, A. J. E., & Mills, E. J. (2011) · Integrative Cancer Therapies · doi:10.1177/1534735411425484 · Cited by 176 · see citing works
Laudon, M., Wade, A. G., Farmer, M. V., Harari, G., Fund, N., Nir, T., Frydman‐Marom, A., & Zisapel, N. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s65625 · Cited by 174 · see citing works
Melatonin: A Sleep-Promoting Hormone
Zhdanova, I. V., Lynch, H. J., & Wurtman, R. J. (1997) · SLEEP · doi:10.1093/sleep/20.10.899 · Cited by 169 · see citing works
Gonçalves, A. L., Martini Ferreira, A., Ribeiro, R. T., Zukerman, E., Cipolla-Neto, J., & Peres, M. F. P. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313458 · Cited by 169 · see citing works
Melatonin reduces night blood pressure in patients with nocturnal hypertension
Grossman, E., Laudon, M., Yalcin, R., Zengil, H., Peleg, E., Sharabi, Y., Kamari, Y., Shen-Orr, Z., & Zisapel, N. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.002 · Cited by 168 · see citing works
Negative effects of melatonin on depression
Carman, J., Post, R. M., Buswell, R., & Goodwin, F. K. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.10.1181 · Cited by 160 · see citing works
Prolonged melatonin administration decreases nocturnal blood pressure in women
CAGNACCI, A., CANNOLETTA, M., RENZI, A., BALDASSARI, F., ARANGINO, S., & VOLPE, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.008 · Cited by 156 · see citing works
du Plessis, S. S., Hagenaar, K., & Lampiao, F. (2010) · Andrologia · doi:10.1111/j.1439-0272.2009.00964.x · Cited by 155 · see citing works
Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag
Suhner, A., Schlagenhauf, P., Johnson, R., Tschopp, A., & Steffen, R. (1998) · Chronobiology International · doi:10.3109/07420529808993201 · Cited by 147 · see citing works
Cagnacci, A., Arangino, S., Renzi, A., Paoletti, A. M., Melis, G. B., Cagnacci, P., & Volpe, A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01232.x · Cited by 139 · see citing works
Luthringer, R., Muzet, M., Zisapel, N., & Staner, L. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832e9b08 · Cited by 136 · see citing works
Ortiz, Á., Espino, J., Bejarano, I., Lozano, G. M., Monllor, F., García, J. F., Pariente, J. A., & Rodríguez, A. B. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00822.x · Cited by 134 · see citing works
THE EFFECTS OF EXOGENOUS MELATONIN ON ENDOCRINE FUNCTION IN MAN
WRIGHT, J., Aldhous, M. E., Franey, C. S., English, J., & Arendt, J. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb01641.x · Cited by 133 · see citing works
Otmani, S., Demazières, A., Staner, C., Jacob, N., Nir, T., Zisapel, N., & Staner, L. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.980 · Cited by 131 · see citing works
Picinato, M. C., Haber, E. P., Cipolla‐Neto, J., Curi, R., Carvalho, C. R. D. O., & Carpinelli, Â. R. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.02903.x · Cited by 126 · see citing works
Espino, J., Ortiz, Á., Bejarano, I., Lozano, G. M., Monllor, F., García, J. F., Rodríguez, A. B., & Pariente, J. A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.063 · Cited by 123 · see citing works
Fabbro, E. D., Dev, R., Hui, D., Palmer, L. J., & Bruera, E. D. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.6766 · Cited by 122 · see citing works
Carr, R. R., Wasdell, M. B., Hamilton, D., Weiss, M. D., Fréeman, R. D., Tai, J., Rietveld, W. J., & Jan, J. E. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00485.x · Cited by 121 · see citing works
Hansen, M. V., Andersen, L. T., Madsen, M. T., Hageman, I., Rasmussen, L. S., Bokmand, S., Rosenberg, J., & Gögenür, I. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2962-2 · Cited by 120 · see citing works
Zanette, S. D. A., Vercelino, R., Laste, G., Rozisky, J. R., Schwertner, A., Machado, C. B., Xavier, F., de Souza, I. C. C., Deitos, A., Torres, I. L. D. S., et al. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-40 · Cited by 117 · see citing works
Lusardi, P., Piazza, E., & Fogari, R. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00195.x · Cited by 115 · see citing works
Role of melatonin in blood pressure regulation: An adjunct anti‐hypertensive agent
Baker, J. R., & Kimpinski, K. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12942 · Cited by 111 · see citing works
Melatonin Administration Alters Semen Quality in Healthy Men
Luboshitzky, R., Shen‐Orr, Z., Nave, R., Lavi, S., & Lavie, P. (2002) · Journal of Andrology · doi:10.1002/j.1939-4640.2002.tb02281.x · Cited by 103 · see citing works
Garaulet, M., Gómez-Abellán, P., Rubio-Sastre, P., Madrid, J. A., Saxena, R., & Scheer, F. A. J. L. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.003 · Cited by 100 · see citing works
Use of melatonin in recovery from jet-lag following an eastward flight across 10 time-zones
Edwards, B., Atkinson, G., Waterhouse, J. M., Reilly, T. P., Godfrey, R., & Budgett, R. (2000) · Ergonomics · doi:10.1080/001401300750003934 · Cited by 93 · see citing works
Wilhelmsen‐Langeland, A., Saxvig, I. W., Pallesen, S., Nordhus, I. H., Vedaa, Ø., Lundervold, A. J., & Bjorvatn, B. (2013) · Journal of Biological Rhythms · doi:10.1177/0748730413500126 · Cited by 92 · see citing works
Chuffa, L. G. D. A., Seiva, F. R. F., Fávaro, W. J., Teixeira, G. R., Amorim, J. P., Mendes, L. D. O., Fioruci, B. A., Pinheiro, P. F. F., Fernandes, A. A. H., Franci, J. A. A., et al. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-108 · Cited by 88 · see citing works
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study
Tagliaferri, V., Romualdi, D., Scarinci, E., De Cicco, S., Di Florio, C., Immediata, V., Tropea, A., Santarsiero, C. M., Lanzone, A., & Apa, R. (2018) · Reproductive Sciences · doi:10.1177/1933719117711262 · Cited by 87 · see citing works
Yürüker, V., Nazıroğlu, M., & Şenol, N. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9623-3 · Cited by 81 · see citing works
Sookprasert, A., Johns, N. P., Phunmanee, A., Pongthai, P., Cheawchanwattana, A., Johns, J. R., Konsil, J., Phiboonchaiyanan, P. P., Porasuphatana, S., & Jitpimolmard, S. (2014) · PubMed · Cited by 79 · see citing works
Poon, A. M. S., Choy, E. H. Y., & Pang, S. (2001) · Neurosignals · doi:10.1159/000046904 · Cited by 75 · see citing works
Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial
Goyal, A., Terry, P., Superak, H. M., Nell‐Dybdahl, C., Chowdhury, R., Phillips, L. S., & Kutner, M. H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-124 · Cited by 74 · see citing works
Melatonin Improves Sleep in Asthma
Campos, F. L., da Silva‐Júnior, F. P., de Bruin, V. M. S., & de Bruin, P. F. C. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-488oc · Cited by 71 · see citing works
Fan, Y., Yuan, L., Ji, M., Yang, J., & Gao, D. (2017) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2017.03.023 · Cited by 71 · see citing works
Blood pressure‐lowering effect of melatonin in type 1 diabetes
Cavallo, A., Daniels, S. R., Dolan, L. M., Bean, J. A., & Khoury, J. C. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00126.x · Cited by 69 · see citing works
Clinical Importance of Melatonin
Wetterberg, L. (1979) · Progress in brain research · doi:10.1016/s0079-6123(08)62962-3 · Cited by 69 · see citing works
Onseng, K., Johns, N. P., Khuayjarernpanishk, T., Subongkot, S., Priprem, A., Hurst, C. P., & Johns, J. R. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0081 · Cited by 69 · see citing works
Pakravan, H., Ahmadian, M., Fani, A., Aghaee, D., Brumanad, S., & Pakzad, B. (2017) · Advanced Biomedical Research · doi:10.4103/2277-9175.204593 · Cited by 67 · see citing works
Calcium‐Dependent Effects of Melatonin Inhibition of Glutamatergic Response in Rat Striatum
Escames, G., Macías, M., León, J., García, J. J., Khaldy, H., Martı́n, M., Vives, F., & Acuña-Castroviejo, D. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00656.x · Cited by 61 · see citing works
Melatonin versus chloral hydrate for recording sleep EEG
Ashrafi, M. R., Mohammadi, M., Tafaroji, J., Shabanian, R., Salamati, P., & Zamani, G. (2009) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2009.06.010 · Cited by 60 · see citing works
Daily Melatonin Administration Attenuates Age-Dependent Disturbances of Cardiovascular Rhythms
Gubin, D. G., Губин, Г. Д., Gapon, L., & Weinert, D. (2015) · Current Aging Science · doi:10.2174/1874609809666151130220011 · Cited by 59 · see citing works
Rechciński, T., Trzos, E., Wierzbowska-Drabik, K. A., Krzemińska‐Pakuła, M., & Kurpesa, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.174 · Cited by 55 · see citing works
Możdżan, M., Możdżan, M., Chałubiński, M., Wojdan, K., & Broncel, M. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.44858 · Cited by 55 · see citing works
Adamczyk-Sowa, M. H., Pierzchała, K., Sowa, P., Polaniak, R., Kukla, M., & Hartel, M. (2014) · PubMed · Cited by 55 · see citing works
Jahromi, B. N., Sadeghi, S., Alipour, S., Parsanezhad, M. E., & Alamdarloo, S. M. (2017) · PubMed Central · Cited by 55 · see citing works
Zisapel, N., Lemoine, Garfinkel, D., Laudon, M., & Nir (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s23036 · Cited by 54 · see citing works
Insomnia Associated with Valerian and Melatonin Usage in the 2002 National Health Interview Survey
Bliwise, D. L., & Ansari, F. P. (2007) · SLEEP · doi:10.1093/sleep/30.7.881 · Cited by 53 · see citing works
Effect of daytime oral melatonin administration on neurobehavioral performance in humans
Rogers, N. L., Phan, O., Kennaway, D. J., & Dawson, D. E. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00385.x · Cited by 50 · see citing works
Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia
Culpepper, L., & Wingertzahn, M. A. (2015) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.15r01798 · Cited by 50 · see citing works
A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers
Schernhammer, E. S., Giobbie‐Hurder, A., Gantman, K., Savoie, J., Scheib, R. G., Parker, L. M., & Chen, W. Y. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9927-8 · Cited by 46 · see citing works
Crowley, S. J., & Eastman, C. I. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2869-8 · Cited by 45 · see citing works
Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women.
Chojnacki, C. J., Walecka‐Kapica, E., Łokieć, K., Pawłowicz, M., Winczyk, K., Chojnacki, J., & Klupińska, G. (2013) · PubMed · Cited by 45 · see citing works
Kirksey, M., Yoo, D. J., Danninger, T., Stundner, O., Ma, Y., & Memtsoudis, S. G. (2015) · The Journal of Arthroplasty · doi:10.1016/j.arth.2015.06.034 · Cited by 44 · see citing works
Baandrup, L., Lindschou, J., Winkel, P., Gluud, C. N., & Glenthoj, B. Y. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1048725 · Cited by 42 · see citing works
Webley, G. E., Böhle, A., & Leidenberger, F. A. (1988) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1988.tb00765.x · Cited by 42 · see citing works
Neurobehavioural performance effects of daytime melatonin and temazepam administration
Rogers, N. L., Kennaway, D. J., & Dawson, D. E. (2003) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2003.00360.x · Cited by 41 · see citing works
Gögenür, I., Kücükakin, B., Bisgaard, T., Kristiansen, V. B., Hjortsø, N.-C., Skene, D. J., & Rosenberg, J. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31819a6cf0 · Cited by 40 · see citing works
Hartz, I., Handal, M., Tverdal, A., & Skurtveit, S. O. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12411 · Cited by 39 · see citing works
Impact of Melatonin on Driving Performance
Suhner, A., Schlagenhauf, P., Tschopp, A., Hauri-Bionda, R., Friedrich-Koch, A., & Steffen, R. J. (1998) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.1998.tb00448.x · Cited by 39 · see citing works
Katz, A., Lemoine, Wade, Nir, & Zisapel (2012) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s27240 · Cited by 39 · see citing works
Ivry, M., Goitein, D., Welly, W., & Berkenstadt, H. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.11.001 · Cited by 38 · see citing works
Melatonin Treatment of Pediatric Residents for Adaptation to Night Shift Work
Cavallo, A., Ris, M. D., Succop, P., & Jaskiewicz, J. A. (2005) · Ambulatory Pediatrics · doi:10.1367/a04-124r.1 · Cited by 37 · see citing works
Ghattassi, K., Hammouda, O., Graja, A., Boudhina, N., Chtourou, H., Hadhri, S., Driss, T., & Souissi, N. (2016) · Acta Physiologica Hungarica · doi:10.1556/036.103.2016.1.9 · Cited by 37 · see citing works
Adamczyk-Sowa, M. H., Sowa, P., Adamczyk, J., Niedziela, N., Misiołek, H., Owczarek, M., & Żwirska-Korczala, K. (2016) · PubMed · Cited by 37 · see citing works
Acute effects of low doses of melatonin on the sleep of young healthy subjects
Pires, M. L. N., Benedito‐Silva, A. A., Pinto, L., Souza, L., Vismari, L., & Calil, H. M. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.310407.x · Cited by 35 · see citing works
Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial
Green, E. A., Black, B. K., Biaggioni, I., Paranjape, S. Y., Bagai, K., Shibao, C., Okoye, M. C., Dupont, W. D., Robertson, D., & Raj, S. R. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12067 · Cited by 33 · see citing works
Javanmard, S. H., Heshmat‐Ghahdarijani, K., Mirmohammadsadeghi, M., Sonbolestan, S., & Ziayi, A. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.194801 · Cited by 31 · see citing works
The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment
Chojnacki, C. J., Błońska, A., & Chojnacki, J. (2017) · BioMed Research International · doi:10.1155/2017/3204504 · Cited by 30 · see citing works
Therapeutic effect of melatonin on pediatric functional dyspepsia: A pilot study
Zybach, K. (2016) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v7.i1.156 · Cited by 26 · see citing works
Litvinenko, I., Krasakov, I. V., & Тихомирова, О. В. (2012) · PubMed · Cited by 24 · see citing works
Pokharel, K., Tripathi, M., Gupta, P., Bhattarai, B., Khatiwada, S., & Subedi, A. (2014) · BioMed Research International · doi:10.1155/2014/356964 · Cited by 24 · see citing works
Zhang, Y., Li, H., Pu, Y., Gong, S., Liu, C., Jiang, X., & Tao, J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12218 · Cited by 23 · see citing works
Effect of nocturnal melatonin ingestion on short-term anaerobic performance in soccer players
Ghattassi, K., Graja, A., Hammouda, O., Chtourou, H., Boudhina, N., Chaouachi, A., & Souissi, N. (2014) · Biological Rhythm Research · doi:10.1080/09291016.2014.929853 · Cited by 22 · see citing works
Effects of melatonin on performance testing in patients with seasonal affective disorder
Sherer, M. A., Weingartner, H., JAMES, S. P., & Rosenthal, N. E. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90066-7 · Cited by 19 · see citing works
Fallah, R., Yadegari, Y., Behdad, S., & Karbasi, S. A. (2014) · PubMed · Cited by 18 · see citing works
Khezri, M. B., Reihany, M. D., Oveisy, S., & Mohammadi, N. (2016) · PubMed Central · Cited by 17 · see citing works
Parandavar, N., Abdali, K., Keshtgar, S., Emamghoreishi, M., & Amooee, S. (2014) · PubMed Central · Cited by 13 · see citing works
Li, Y., Liu, H., Sun, J., Tian, Y., & Li, C. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3833 · Cited by 11 · see citing works
Department of Health and Ageing Therapeutic Goods Administration
Hawthorn, E. (2013) · Cited by 10 · see citing works
Ucar, E., Lehtinen, E. K., Glenthoj, B. Y., & Oranje, B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111430752 · Cited by 8 · see citing works
Melatonin versus Gabapentin. A comparative study as preemptive medications
(2010) · The Internet Journal of Anesthesiology · doi:10.5580/265 · Cited by 8 · see citing works
Rechciński, T., Uznańska‐Loch, B., Trzos, E., Wierzbowska-Drabik, K. A., Krzemińska‐Pakuła, M., Kasprzak, J. D., & Kurpesa, M. (2012) · PubMed · Cited by 7 · see citing works
Influence of Melatonin on Sleep in Humans
Cramer, H., Kendel, K., & Beck, U. (2015) · Sleep · doi:10.1159/000428116 · Cited by 5 · see citing works
[Melatonin in combined therapy of patients with stable angina and arterial hypertension].
Rm, Z., Shcherban', E. A., & Logvinenko, S. I. (2008) · PubMed · Cited by 4 · see citing works
Cheng, C., Gooneratne, N. S., Payton, C., Keith, S. W., & Hafycz, J. (2016) · Hypertension · doi:10.1161/hyp.68.suppl_1.p308 · Cited by 1 · see citing works
Flagged first, then by citations
3 of the 107 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
Talib, W. H., Alsayed, A. R., Abuawad, A., Daoud, S., & Mahmod, A. I. (2021) · Molecules · doi:10.3390/molecules26092506 · Cited by 223 · see citing works
Sleep and Diet: Mounting Evidence of a Cyclical Relationship
Zuraikat, F. M., Wood, R. A., Barragán, R., & St‐Onge, M. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-021719 · Cited by 212 · see citing works
Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J. (2022) · Nutrients · doi:10.3390/nu14193934 · Cited by 176 · see citing works
Besag, F., Vasey, M. J., Lao, K. S. J., & Wong, I. C. K. (2019) · CNS Drugs · doi:10.1007/s40263-019-00680-w · Cited by 170 · see citing works
Safety of higher doses of melatonin in adults: A systematic review and meta-analysis
Menczel Schrire, Z., Phillips, C. L., Chapman, J. L., Duffy, S. L., Wong, G., D’Rozario, A. L., Comas, M., Raisin, I., Saini, B., Gordon, C. J., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12782 · Cited by 133 · see citing works
Clinical Application of Antioxidants to Improve Human Oocyte Mitochondrial Function: A Review
Rodríguez-Varela, C., & Labarta, E. (2020) · Antioxidants · doi:10.3390/antiox9121197 · Cited by 116 · see citing works
“The main advantage of melatonin antioxidant therapy is its relatively well-documented safety due to its frequent use as a sleep aid [101].”
BackgroundTherapeutic Algorithm for Use of Melatonin in Patients With COVID-19
Reiter, R. J., Abreu-González, P., Marik, P. E., & Domínguez‐Rodríguez, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00226 · Cited by 105 · see citing works
El-Missiry, M. A., El-Missiry, Z. M. A., & Othman, A. I. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173329 · Cited by 98 · see citing works
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
Griñán‐Lisón, C., Blaya-Cánovas, J. L., López-Tejada, A., Ávalos-Moreno, M., Navarro-Ocón, A., Cara, F. E., González-González, A., Lorente, J. A., Marchal, J. A., & Granados-Principal, S. M. (2021) · Antioxidants · doi:10.3390/antiox10020205 · Cited by 98 · see citing works
Melatonin for the treatment of sepsis: the scientific rationale
Biancatelli, R. M. L. C., Berrill, M., Mohammed, Y. H., & Marik, P. E. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.12.85 · Cited by 95 · see citing works
“In a meta-analysis of 50 studies evaluating the efficacy of oral melatonin supplementation (1 to 20 mg) (147), nearly half reported adverse effects, often transient, associated with daytime dosing and commonly as drowsiness and fatigue.”
BackgroundInsight into the roles of melatonin in bone tissue and bone-related diseases (Review)
Lu, X., Yu, S.-L., Chen, G., Zheng, W., Peng, J., Huang, X., & Chen, L.-L. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4915 · Cited by 67 · see citing works
Use of Melatonin in Cancer Treatment: Where Are We?
Wang, L., Wang, C., & Choi, W. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073779 · Cited by 92 · see citing works
“The reported adverse events were mostly related to psychomotor and neurocognitive dysfunctions, fatigue, and excessive sleepiness [126], which could be avoided by taking melatonin at night and using the proper dosage with short-term administration.”
BackgroundMelatonin for preoperative and postoperative anxiety in adults
Madsen, B. K., Zetner, D. B., Møller, A. M., & Rosenberg, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009861.pub3 · Cited by 90 · see citing works
Light and Circadian Signaling Pathway in Pregnancy: Programming of Adult Health and Disease
Hsu, C., & Tain, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062232 · Cited by 82 · see citing works
Tuft, C., Matar, E., Schrire, Z. M., Grunstein, R. R., Yee, B. J., & Hoyos, C. M. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s361519 · Cited by 72 · see citing works
“66% of patients compared to placebo, though this was not considered significant.(30,31) It is not clear if this was related to early administration of melatonin.”
BackgroundInfluentialSignificance of Melatonin in the Regulation of Circadian Rhythms and Disease Management
Megha, K. B., Arathi, A., Shikha, S., Alka, R., Ramya, P., & Mohanan, P. V. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03915-0 · Cited by 68 · see citing works
“A systematic review and meta-analysis of randomised clinical trials involving the use of melatonin with and without chemotherapy reported that in the former, the mortality of the patients was decreased with a reduction in side effects like leukopenia, thrombocytopenia, nausea and vomiting [259].”
The emergence of melatonin in oncology: Focus on colorectal cancer
Gil‐Martín, E., Egea, J., Reiter, R. J., & Romero, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21582 · Cited by 67 · see citing works
“significant adverse events attributed to melatonin; a lot of them were short life (sleepiness, headache, or fatigue), whereas other more serious side effects were seen at very high doses or in specific populations.(365) In this context, some reports have evidenced that short‐term melatonin can sometimes lead to opposi…”
BackgroundEffects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review
Imenshahidi, M., Karimi, G., & Hosseinzadeh, H. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01822-4 · Cited by 66 · see citing works
Ahmed, J., Pullattayil, A. K., Robertson, N. J., & More, K. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.02.003 · Cited by 61 · see citing works
Delpino, F. M., Figueiredo, L. M., & Nunes, B. P. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.06.007 · Cited by 56 · see citing works
An Assessment of Melatonin’s Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn
Cardinali, D. P. (2019) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2019.00034 · Cited by 52 · see citing works
“It crosses readily the blood-brain barrier, its antioxidant and anti-inflammatory effects are readily exerted and it has an excellent safety profile (Gitto et al., 2001, 2009; Welin et al., 2007; Foley and Steel, 2019).”
BackgroundYuge, K., Nagamitsu, S., Ishikawa, Y., Hamada, I., Takahashi, H., Sugioka, H., Yotsuya, O., Mishima, K., Hayashi, M., & Yamashita, Y. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02847-y · Cited by 57 · see citing works
Zhang, T., Wang, L., Duan, X., Niu, Y., Li, M., Li, Y., Sun, H., Ma, Y., & Guo, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1281213 · Cited by 48 · see citing works
“However, other studies have reported doubts about the ef fi cacy of melatonin in treating OP (105), and concerns about its side effects have been raised (106, 107).”
BackgroundThe usefulness of melatonin in the field of obstetrics and gynecology
Genário, R., Morello, E., Bueno, A. A., & Santos, H. O. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104337 · Cited by 45 · see citing works
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Romero, A., Ramos, E., Lopez-Munoz, F. J., Gil‐Martín, E., Escames, G., & Reiter, R. J. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00938-8 · Cited by 44 · see citing works
Händel, M. N., Andersen, H., Ussing, A., Virring, A., Jennum, P., Debes, N. M., Laursen, T., Baandrup, L., Gade, C., Nielsen, J. D., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102083 · Cited by 43 · see citing works
Melatonin Inhibits Osteoclastogenesis and Osteolytic Bone Metastasis: Implications for Osteoporosis
MacDonald, I. J., Tsai, H., Chang, A., Huang, C., Yang, S., & Tang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179435 · Cited by 41 · see citing works
“and headache; no dose has been linked to serious adverse effects [12,14].”
BackgroundPediatric use of prescribed melatonin in Sweden 2006–2017: a register based study
Kimland, E. E., Bardage, C., Collin, J., Järleborg, A., Ljung, R., & Iliadou, A. N. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01598-1 · Cited by 39 · see citing works
“However, little is known regarding safety and adverse effects of long-term use in the pediatric population [17, 20, 21].”
BackgroundResultMantle, D., Smits, M. G., Boss, M., Miedema, I., & van Geijlswijk, I. M. (2020) · Sleep Medicine X · doi:10.1016/j.sleepx.2020.100022 · Cited by 41 · see citing works
“These events were generally minor, short-lived and easily managed, eg by dosing in accordance with natural circadian rhythms [163].”
BackgroundEarly Origins of Hypertension: Should Prevention Start Before Birth Using Natural Antioxidants?
Hsu, C., & Tain, Y. (2020) · Antioxidants · doi:10.3390/antiox9111034 · Cited by 39 · see citing works
Perinatal Use of Melatonin for Offspring Health: Focus on Cardiovascular and Neurological Diseases
Hsu, C., Huang, L., & Tain, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225681 · Cited by 37 · see citing works
“Fatigue, excessive sleepiness, and reductions in psychomotor and neurocognitive function are the most frequently reported adverse reactions [47].”
BackgroundPérez‐Llamas, F., Hernández‐Ruíz, J., Cuesta, A., Zamora, S., & Arnao, M. B. (2020) · Antioxidants · doi:10.3390/antiox9020158 · Cited by 36 · see citing works
“), makes it interesting to bet on active materials of natural origin, in addition to raising quality levels and their controls [75].”
BackgroundDelpino, F. M., & Figueiredo, L. M. (2021) · Nutrition · doi:10.1016/j.nut.2021.111399 · Cited by 36 · see citing works
Melatonin's efficacy in stroke patients; a matter of dose? A systematic review
Ramos, E., Farré‐Alins, V., Egea, J., Lopez-Munoz, F. J., Reiter, R. J., & Romero, A. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114933 · Cited by 32 · see citing works
Lim, S., Park, S., Koyanagi, A., Yang, J. W., Jacob, L., Yon, D. K., Lee, S. W., Kim, M. S., Shin, J. I., & Smith, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2021.106052 · Cited by 32 · see citing works
Melatonin and Vascular Function
Mendes, L., Queiroz, M., & Sena, C. M. (2024) · Antioxidants · doi:10.3390/antiox13060747 · Cited by 31 · see citing works
What do we really know about the safety and efficacy of melatonin for sleep disorders?
Kennaway, D. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.2000714 · Cited by 31 · see citing works
Ameri, A., Asadi, M. F., Ziaei, A., Vatankhah, M., Safa, O., Kamali, M., Fathalipour, M., Mahmoodi, M., & Hassanipour, S. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01096-7 · Cited by 31 · see citing works
“But in some cases, adverse drug events such as dizziness were also observed (Foley and Steel 2019).”
BackgroundMelatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
Cardinali, D. P., Brown, G. M., & Pandi-Perumal, S. R. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s380465 · Cited by 30 · see citing works
“A comprehensive study of the negative consequences of oral melatonin supplementation has been conducted.(116) 26 of the 50 publications revealed no statistically significant adverse events, whereas 24 reported at least one statistically significant adverse event.”
BackgroundMelatonin and Prostate Cancer: Anti-tumor Roles and Therapeutic Application
Megerian, M. F., Kim, J., Badreddine, J., Hong, S. H., Ponsky, L. E., Shin, J. I., & Ghayda, R. A. (2022) · Aging and Disease · doi:10.14336/ad.2022.1010 · Cited by 30 · see citing works
“Considering that there were no major side effects related to melatonin except for minor psychological or neurocognitive problems [157], we recommend a higher dosage for a definite anti-tumor activity.”
BackgroundFard, R. M., Rashno, M. M., & Bahreiny, S. S. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.07.015 · Cited by 29 · see citing works
Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics
Capote-Moreno, A. L., Ramos, E., Egea, J., Lopez-Munoz, F. J., Gil‐Martín, E., & Romero, A. (2019) · Cancers · doi:10.3390/cancers11111712 · Cited by 28 · see citing works
“In the case of melatonin, it has recently been reported that even at high doses, and aside from some rare exceptions, both physiological and pharmacological concentrations have no significant toxicity [54].”
BackgroundPotential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer
Pourmohammad, P., Maroufi, N. F., Rashidi, M., Vahedian, V., Pouremamali, F., Faridvand, Y., Ghaffari-Novin, M., Isazadeh, A., Hajazimian, S., Nejabati, H. R., et al. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10104-4 · Cited by 27 · see citing works
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
Ramos, E., Lopez-Munoz, F. J., Gil‐Martín, E., Egea, J., Álvarez‐Merz, I., Painuli, S., Semwal, P., Martins, N. A., Hernández-Guijo, J. M., & Romero, A. (2021) · Antioxidants · doi:10.3390/antiox10071152 · Cited by 25 · see citing works
“There is, apparently, a lack of serious adverse effects after its supplementation [68].”
BackgroundToxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
Romero, A., Ramos, E., Lopez-Munoz, F. J., Rı́os, C. D. L., Egea, J., Gil‐Martín, E., Pita, R. P., Torrado, J. J., Serrano, D. R., & Juberías, A. (2021) · Diseases · doi:10.3390/diseases9020027 · Cited by 25 · see citing works
“Despite there are no serious adverse effects described, a particular population has been suggested to be monitored to clarify this relatively safe profile [7].”
BackgroundInfluentialBueno, A. P. R., Savi, F. M., Alves, I. A., & Bandeira, V. A. C. (2021) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2020-0379 · Cited by 24 · see citing works
Castro‐Marrero, J., Zaragozá, M. C., López-Vílchez, I., Galmés, J. L., Cordobilla, B., Maurel, S., Domingo, J. C., & Alegre, J. (2021) · Antioxidants · doi:10.3390/antiox10071010 · Cited by 22 · see citing works
“The most frequently reported adverse effects were daytime sleepiness, headache, and dizziness [22].”
BackgroundMelatonin: A window into the organ-protective effects of sepsis
Liu, R., Luo, X., Li, J., Lei, Y., Fan, Z., Huang, X., Lan, Y., & Yang, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113556 · Cited by 22 · see citing works
Farid, A., Michael, V. H., & Safwat, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-43546-4 · Cited by 21 · see citing works
RetractedMelatonin Treatment for Pediatric Patients with Insomnia: Is There a Place for It?
Rolling, J., Rabot, J., & Schroder, C. M. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s340944 · Cited by 19 · see citing works
Kiabi, F. H., Emadi, S. A., Ebadi, A., Aezzi, G., & Ahmadi, N. S. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102345 · Cited by 19 · see citing works
“A review reported long-term side effects of melatonin like dizziness, drowsiness and somnolence in patients undergoing general anesthesia surgery [41] and cognitive decline in elderly patients under general anesthesia in hip surgery [42,43].”
BackgroundAmiri, P., Hosseini, S. A., Roshanravan, N., Saghafi‐Asl, M., & Tootoonchian, M. (2023) · Trials · doi:10.1186/s13063-022-06891-9 · Cited by 18 · see citing works
Cassimatis, M., Browne, G. J., & Orr, R. (2022) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2022.09.018 · Cited by 17 · see citing works
Melatonin, a natural antioxidant therapy in spinal cord injury
Xie, L., Wu, H., Huang, X., & Yu, T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1218553 · Cited by 17 · see citing works
“However, a clinical trial indicated no significant difference between melatonin and placebo arms in the rate of adverse events, even at a dose as high as 1,600 mg/day (Foley and Steel, 2019).”
BackgroundMelatonin’s Impact on Wound Healing
Sohn, E., Kim, S., & Lee, S. R. (2024) · Antioxidants · doi:10.3390/antiox13101197 · Cited by 17 · see citing works
“Melatonin is generally considered a safe supplement for short-term use, with a low incidence of serious side effects [18,34,226–230].”
BackgroundSeo, K., Kim, J., & Han, D. (2023) · Healthcare · doi:10.3390/healthcare11050675 · Cited by 16 · see citing works
“A review paper on adverse effects of melatonin administration studies involving various types of disease also reported that there were either no adverse effects or that the adverse effects were minor and controllable [39].”
BackgroundLi, C., Ma, D., Li, M., Wei, T., Zhao, X., Heng, Y., Ma, D., Anto, E. O., Zhang, Y., Niu, M., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.737972 · Cited by 16 · see citing works
“Some studies also showed that melatonin had no side effects in the short term and had mild side effects in the long term (59, 64).”
BackgroundRatwani, M., Bisht, S., & Prakash, S. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151978 · Cited by 20 · see citing works
Ramos, E., Egea, J., Lopez-Munoz, F. J., Gil‐Martín, E., & Romero, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061616 · Cited by 15 · see citing works
Adverse events in long-term studies of exogenous melatonin
Besag, F., & Vasey, M. J. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2160444 · Cited by 15 · see citing works
“Furthermore, analyses of the data from double-blind, placebocontrolled studies of the adverse effects of short-term treatment with melatonin have also revealed no serious adverse effects [77,78].”
BackgroundAlaa, H., Abdelaziz, M. S., Mustafa, M., Mansour, M., Magdy, S., Mohsen, S., Elkaramany, Y., & Farid, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-36929-0 · Cited by 15 · see citing works
RetractedHa, M., Yoon, D., Lee, C., Lee, M.-S., Kim, Y., Lee, J., & Shin, J. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12949 · Cited by 14 · see citing works
“27 However, these studies noted that such effects were likely to be observed when melatonin was administered immediately before testing or during daylight hours; this suggests that the timing and dosage of melatonin administration may influence adverse psychiatric and behavioral events.”
BackgroundMelatonin for Insomnia in Medical Inpatients: A Narrative Review
Salahub, C. M., Wu, P. E., Burry, L. D., Soong, C., Sheehan, K., MacMillan, T. E., & Lapointe‐Shaw, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010256 · Cited by 12 · see citing works
“In a systematic review of clinical studies, adverse drug events from melatonin were unlikely to occur (reported in 24 out of 50 studies) and most were associated with daytime dosing, very high doses, or in specific patient populations [36].”
BackgroundInfluentialMelatonin and TGF-β-Mediated Release of Extracellular Vesicles
Piekarska, K., Bonowicz, K., Grzanka, A., Jaworski, Ł. M., Reiter, R. J., Slominski, A. T., Steinbrink, K., Kleszczyński, K., & Gagat, M. (2023) · Metabolites · doi:10.3390/metabo13040575 · Cited by 13 · see citing works
Amstrup, A. K., & Rejnmark, L. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103026 · Cited by 14 · see citing works
Wang, L., Su, Y., & Choi, W. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189907 · Cited by 13 · see citing works
“Besides the anticancer effects, melatonin has a favorable safety profile without major adverse events [47].”
BackgroundPotential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection
Shchetinin, E., Батурин, В. А., Arushanyan, E., Bolatchiev, A., & Bobryshev, D. (2022) · Antioxidants · doi:10.3390/antiox11010140 · Cited by 13 · see citing works
Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study
Høier, N. K., Madsen, T., Spira, A. P., Hawton, K. E., Jennum, P., Nordentoft, M., & Erlangsen, A. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10118 · Cited by 12 · see citing works
Use of Melatonin Is Associated With Lower Risk of Colorectal Cancer in Older Adults
Zhang, N., Sundquist, J., Sundquist, K., & Ji, J. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000396 · Cited by 12 · see citing works
Insomnia in Children Affected by Autism Spectrum Disorder: The Role of Melatonin in Treatment
Bruni, O., Biggio, G., Malorgio, E., & Nobili, L. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.05.046 · Cited by 11 · see citing works
Exploring the association between melatonin and nicotine dependence (Review)
GEORGAKOPOULOU, V. E., Sklapani, P., Τράκας, Ν., Reiter, R. J., & Spandidos, D. A. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5406 · Cited by 12 · see citing works
“Unlike some pharmacotherapies, melatonin is a naturally occurring molecule with few adverse effects, making it suitable for long‑term use (101,102).”
Conversation With Kara Parker, MD: Caring for the Underserved Population During COVID-19.
Evans, J. M., Luby, R., Lukaczer, D., Rountree, R., Stone, P. M., Guilliams, T. G., Yanuck, S. F., Messier, H., Ramsdell, K., & Hanaway, P. J. (2020) · PubMed Central · Cited by 11 · see citing works
Thanawala, S., Abiraamasundari, R., & Shah, R. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101248 · Cited by 10 · see citing works
“The most common AEs were related to fatigue, mood, or psychomotor and neurocognitive performance which were generally short-lived and associated with day-time dosing [32].”
BackgroundMelatonin's paradox: From therapeutic benefits to toxicity warnings
Amrollahi‐Sharifabadi, M., Oladejo, T. O., Ibrahim, A. S., Shakoor, B., Mehrpour, O., Hashjin, G. S., & Gonçalves, S. D. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111556 · Cited by 11 · see citing works
Wang, Z., Li, Y., Lin, D., & Ma, J. (2020) · Pain Practice · doi:10.1111/papr.12948 · Cited by 10 · see citing works
Developmental and Early Life Origins of Hypertension: Preventive Aspects of Melatonin
Tain, Y., & Hsu, C. (2022) · Antioxidants · doi:10.3390/antiox11050924 · Cited by 9 · see citing works
“The main reported adverse effects include fatigue, excessive sleepiness, and reductions in neurocognitive and psychomotor function [65].”
BackgroundRoostaei, G., Rad, N. K., Rahimi, B., Asgari, A., Mosalanejad, S., Kazemizadeh, H., Edalatifard, M., & Abtahi, H. (2025) · Brain and Behavior · doi:10.1002/brb3.70282 · Cited by 8 · see citing works
D’Angelo, A., Lixi, F., Vitiello, L., Gagliardi, V., Pellegrino, A., & Giannaccare, G. (2025) · BioMed Research International · doi:10.1155/bmri/6654976 · Cited by 8 · see citing works
“All the described compounds have shown minimal toxicity in the clinical research reported in the literature, with the exception of curcumin [122], coenzyme Q10 [240], ALA [241], melatonin [242], PUFA [243], and zinc [244], which have shown some adverse e ff ects and drug interactions (Table 2).”
Ahmed, J., Patel, W., Pullattayil, A. K., & Razak, A. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-320592 · Cited by 7 · see citing works
Crosstalk between copper, Alzheimer’s disease, and melatonin
Deepika, Thakur, A., Panghal, A., Pundir, R., Singh, C., Goyal, M., Namdeo, A. G., & Kumar, J. (2025) · BioMetals · doi:10.1007/s10534-025-00712-7 · Cited by 6 · see citing works
“In clinical trials of melatonin for primary or secondary sleep disorders, adverse effects were frequently low to moderate in severity, self-limiting, or dissipated promptly after treatment (Foley and Steel 2019).”
Bhaskar, R., Narayanan, K. B., Singh, D. K. K., & Han, S. S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050381989250626071304 · Cited by 6 · see citing works
Mohammadi, S., Ashtary‐Larky, D., Erfanian-Salim, M., Alaghemand, N., Yousefi, M., Pirayvatlou, P. S., Mirkarimi, M., Mavi, S. A., Alavi, I., Ettehad, Y., et al. (2025) · Nutrients · doi:10.3390/nu18010134 · Cited by 9 · see citing works
“Another review reported that melatonin supplementation generally has a favorable safety profile [171].”
Hakiminia, B., Alikiaii, B., Khorvash, F., & Mousavi, S. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.013 · Cited by 6 · see citing works
Hart, D. A., Zernicke, R. F., & Shrive, N. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179949 · Cited by 6 · see citing works
“, 2021 [74], and some adverse events have been noted Foley and Steel, 2019 [75].”
BackgroundMethodLing, W., Yang, C., Ho, M., & Lee, J. J. (2025) · Nursing and Health Sciences · doi:10.1111/nhs.70075 · Cited by 5 · see citing works
“However, these treatments may cause side effects, such as fatigue, dizziness, low blood pressure, cognitive impairment, and confusion, and could even increase the risk of in-hospital falls (Foley and Steel 2019; Herzig et al. 2021; White et al. 2023).”
Peltz, J. S., & Rogge, R. D. (2023) · Sleep and Biological Rhythms · doi:10.1007/s41105-023-00506-9 · Cited by 5 · see citing works
“In fact, rates of melatonin usage across the U.S. have risen five-fold over the past 2 decades [10], and recent reports have questioned the relative safety of melatonin [11], particularly in regard to suicidal ideation [12].”
Perspective on the Formation, Analysis, and Health Effects of Neuroactive Compounds in Foods
Yılmaz, C., & Gökmen, V. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c05181 · Cited by 5 · see citing works
Solà, E., Morales-Garcia, J. A., Lopez-Munoz, F. J., Ramos, E., & Romero, A. (2025) · Antioxidants · doi:10.3390/antiox14060712 · Cited by 4 · see citing works
Influence of Acute Melatonin Administration on Human Physical Performance: A Systematic Review
Faria, V. S., Messias, L. H. D., Pejon, T. M. M., & Beck, W. R. (2023) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381231155142 · Cited by 4 · see citing works
“15 Compelling evidence has demonstrated the association of melatonin with a depressive effect on the central nervous system, 10,41 reduced alertness, 4,21,32,52 and decreased body temperature.”
BackgroundAn online survey among general pediatricians on melatonin use in children with chronic insomnia
Bruni, O., Breda, M., Malorgio, E., Brambilla, P., Ceschin, F., Pilla, A. D., Elia, M., & Ferri, R. (2023) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2023.11.004 · Cited by 4 · see citing works
Melatonin and neurodegeneration: From neurotoxic environment to cell resilience
Ramos, E., Gil‐Martín, E., & Romero, A. (2019) · Advances in molecular toxicology · doi:10.1016/b978-0-444-64293-6.00003-8 · Cited by 4 · see citing works
Haghparast, P., Pondrom, M., & Ray, S. D. (2020) · Side effects of drugs annual · doi:10.1016/bs.seda.2020.08.008 · Cited by 4 · see citing works
Protective Effects of Melatonin Against PM2.5-Induced Lung Damage
Özdemir, İ., Muluk, N. B., Karahan, M. B., Dönmez, D. B., & Cingi, C. (2025) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000011556 · Cited by 3 · see citing works
Therapeutic potential of melatonin in musculoskeletal medicine
Migliorini, F., Schäfer, L., Simeone, F., Memminger, M. K., Eschweiler, J., & Vaishya, R. (2025) · Journal of Orthopaedics · doi:10.1016/j.jor.2025.11.011 · Cited by 3 · see citing works
Bejarano, I., Jiménez‐Jorge, S., Lobo-Acosta, M. Á., López, A. I. Á., Rosso-Fernández, C. M., Ruiz, R. L., Eichau, S., Ruíz-Peña, J. L., Geniz, M. A., Ampuero, J., et al. (2026) · CNS Drugs · doi:10.1007/s40263-025-01261-w · Cited by 3 · see citing works
“Although large-scale randomised clinical trials that evaluate chronic high-dose melatonin administration remain limited, existing studies confirm its low toxicity and favourable safety profile [18, 20].”
Melatonin as a protector against endocrine disruption across tissues: A systematic review
Isingizwe, C., Ndinganire, G., & Alagbonsi, A. I. (2026) · Physiological Reports · doi:10.14814/phy2.71049 · Cited by 3 · see citing works
“Systematic reviews of longer-term ( ≥ 6 months) prospective studies have found a persistent scarcity of rigorously monitored safety data (Foley & Steel, 2019), and current guidance generally recommends short-duration use pending further evidence (Colitta et al., 2026).”
The latest emerging drugs for the treatment of diabetic cardiomyopathy
Li, M., Liu, L., Zhang, C., Deng, L., Zhong, Y., Liao, B., Li, X., Wan, Y., & Feng, J. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2347468 · Cited by 3 · see citing works
“The main adverse effects of melatonin are associated with reduced psychomotor and neurocognitive function or fatigue and excessive somnolence, whereas its cardiovascular-related adverse events are not significant [142].”
BackgroundVaresio, C., Franco, V., Pasca, L., Celario, M., Fattore, C., Fedele, G., Rota, P., Palmisani, M., & GIORGIS, V. D. (2023) · Metabolites · doi:10.3390/metabo13030383 · Cited by 3 · see citing works
“Melatonin has been demonstrated to be safe and short treatment at low doses has almost no side effects in the healthy population [10].”
BackgroundMiguel, A. M., Cacharro, L. M., Santamaría, G., Garrosa, M., Miguel, M. C. S., Roche, E., Garrosa, E., & Fernández‐Lázaro, D. (2025) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2025.1594733 · Cited by 4 · see citing works
Exogenous Melatonin Use in University Students: A Cross-Sectional Survey
Alqutub, S. T., Alzahrani, F. A., Hassan, A. S., Alirbidi, A. H., Alraddadi, O. A., AlSadah, O. A., Yamani, M. B., & Tobaiqy, M. A. (2024) · Pharmacy · doi:10.3390/pharmacy12020041 · Cited by 2 · see citing works
“Moreover, evidence from 26 RCTs concluded that exogenous AEs can be avoided when it can be administered in accordance with the biological circadian rhythm [19].”
Background
- Authors
- Foley, H. M., & Steel, A. E.
- Affiliations
- Endeavour College of Natural Health (AU)
- Corresponding author
- Foley, Hope M.
- Venue
- Complementary Therapies in Medicine
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 42
- Pages
- 65-81
- ISSN
- 0965-2299 (ISSN-L)
- OpenAlex
- W2898688630
- Cited by
- 144
- References
- 107
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 21 · 2023: 17 · 2022: 20 · 2021: 25 · 2020: 20 · 2019: 8
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Complementary Therapies in Medicine (publishedVersion)
- PubMed (publishedVersion)
- OPUS - Open Publications of UTS Scholars (University of Technology Sydney) (submittedVersion)
- Funders
- Complementary Medicines Australia
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
- Keywords
- melatonin, oral supplementation, adverse events, drug safety, sleep aids, off-label drug use, self-prescription, fatigue, mood, neuropsychological performance, cardiovascular effects, glucose metabolism, reproductive parameters, antihypertensive drug interactions, endocrine interactions
- MeSH terms
- Administration, Oral, Animals, Humans, Melatonin, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review